The Effect of Tryptanthrin and Its Oxime on the Blood-Brain Barrier Permeability in Rats with Cerebral Infarction

Bull Exp Biol Med. 2025 Jun;179(2):206-210. doi: 10.1007/s10517-025-06459-y. Epub 2025 Aug 29.

Abstract

A comparative study of the effect of tryptanthrin and its oxime (Tr-Ox) on the blood-brain barrier (BBB) permeability was conducted in male Wistar rats with cerebral infarction (CI) modeled by intraluminal occlusion of the middle cerebral artery. In 3, 48, and 72 h after CI, extravasation of Evans blue bound to serum albumin in the cerebral hemispheres was assessed 3 h after its intravenous administration (3 ml/kg, 2% solution). Tryptanthrin and Tr-Ox were injected intraperitoneally in a dose of 10 mg/kg on the 30th minute of ischemia and then daily for 2 days. There were no significant differences in the effects of these compounds 3 and 48 h after CI. In both experimental groups, the dye concentration in the left (affected) hemisphere significantly decreased after 3 and 48 h by 30-37 and 51-54%, respectively, in comparison with the control (CI without treatment); in the right hemisphere, dye concentration decreased by 34-39% after 48 h. After 72 h, 45% reduction in Evans blue extravasation in the affected hemisphere was found only in the Tr-Ox group. The ability of tryptanthrin and Tr-Ox to reduce the BBB permeability in the CI acute period is mainly due to the anti-inflammatory effect of these compounds. The protective effect of Tr-Ox, which can affect the JNK1/3 signaling pathway, was more prolonged.

Keywords: blood–brain barrier; cerebral infarction; rats; tryptanthrin; tryptanthrin oxime.

MeSH terms

  • Animals
  • Blood-Brain Barrier* / drug effects
  • Blood-Brain Barrier* / metabolism
  • Capillary Permeability / drug effects
  • Cerebral Infarction* / drug therapy
  • Cerebral Infarction* / metabolism
  • Cerebral Infarction* / pathology
  • Evans Blue
  • Male
  • Oximes* / pharmacology
  • Oximes* / therapeutic use
  • Permeability / drug effects
  • Quinazolines* / pharmacology
  • Quinazolines* / therapeutic use
  • Rats
  • Rats, Wistar

Substances

  • tryptanthrine
  • Quinazolines
  • Oximes
  • Evans Blue